Literature DB >> 21464144

Central nervous system cancers.

Steven S Brem1, Philip J Bierman, Henry Brem, Nicholas Butowski, Marc C Chamberlain, Ennio A Chiocca, Lisa M DeAngelis, Robert A Fenstermaker, Allan Friedman, Mark R Gilbert, Deneen Hesser, Larry Junck, Gerald P Linette, Jay S Loeffler, Moshe H Maor, Madison Michael, Paul L Moots, Tara Morrison, Maciej Mrugala, Louis Burt Nabors, Herbert B Newton, Jana Portnow, Jeffrey J Raizer, Lawrence Recht, Dennis C Shrieve, Allen K Sills, Frank D Vrionis, Patrick Y Wen.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21464144     DOI： 10.6004/jnccn.2011.0036

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  40 in total

Review 1.  Leptomeningeal Carcinomatosis in Esophageal Cancer: Case Report and Review of Literature.

Authors:  Amardeep Singh Aulakh; Amanpreet Buttar; Bilal Piperdi
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Elderly patients with glioblastoma multiforme treated with concurrent temozolomide and standard- versus abbreviated-course radiotherapy.

Authors:  Christine N Chang-Halpenny; Jekwon Yeh; Winston W Lien
Journal:  Perm J       Date:  2015

3.  Is there effective systemic therapy for recurrent surgery- and radiation-refractory meningioma?

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-01

4.  Magnetic resonance imaging of solitary brain metastases: main findings of nonmorphological sequences.

Authors:  S Gaudino; G M Di Lella; R Russo; V S Lo Russo; F Piludu; F R Quaglio; M R Gualano; C De Waure; C Colosimo
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

5.  Cost-effectiveness analysis of the bevacizumab-irinotecan regimen in the treatment of primary glioblastoma multiforme recurrences.

Authors:  Daniel Ruiz-Sánchez; Irene Iglesias Peinado; Miguel Alaguero-Calero; Alejandro José Sastre-Heres; Benito García Diez; Jaime Peña-Díaz
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

6.  A 56-year-old man with acute vision loss.

Authors:  Fani Akritidou; Maria Karafyloglou; Dimitrios Karamanis
Journal:  Digit J Ophthalmol       Date:  2016-08-18

7.  Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimen.

Authors:  Daniel Ruiz-Sánchez; Miguel Alaguero Calero; Alejandro José Sastre-Heres; María Teresa Iglesias García; Miguel Angel Calleja Hernandez; Fernando Martínez Martinez; Jaime Peña-Díaz
Journal:  Oncol Lett       Date:  2012-08-14       Impact factor: 2.967

8.  Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.

Authors:  Peter Baumgarten; Anna-Eva Blank; Kea Franz; Elke Hattingen; Maika Dunst; Pia Zeiner; Katharina Hoffmann; Oliver Bähr; Lisa Mäder; Benjamin Goeppert; Marcia Machein; Volker Seifert; Joachim P Steinbach; Karl H Plate; Patrick N Harter; Michel Mittelbronn
Journal:  Neuro Oncol       Date:  2015-11-30       Impact factor: 12.300

Review 9.  State of the art and perspectives in the treatment of glioblastoma.

Authors:  Sean A Grimm; Marc C Chamberlain
Journal:  CNS Oncol       Date:  2012-09

10.  IFN-α for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series.

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.